Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China · Delayed Price · Currency is CNY 22.25
-0.70 (-3.05%)
At close: Jul 21, 2026
SHE:301584 Revenue
Shanghai C&D INNOSTIC Medical Technology Group had revenue of 4.52B CNY in the quarter ending March 31, 2026, with 1.96% growth. This brings the company's revenue in the last twelve months to 19.44B, up 7.64% year-over-year. In the year 2025, Shanghai C&D INNOSTIC Medical Technology Group had annual revenue of 19.43B with 8.41% growth.
Revenue (ttm)
19.44B
Revenue Growth
+7.64%
P/S Ratio
0.50
Revenue / Employee
9.19M
Employees
2,115
Market Cap
9.67B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.43B | 1.51B | 8.41% |
| Dec 31, 2024 | 17.92B | 2.48B | 16.06% |
| Dec 31, 2023 | 15.44B | 3.56B | 29.97% |
| Dec 31, 2022 | 11.88B | 1.86B | 18.54% |
| Dec 31, 2021 | 10.02B | 1.48B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Wanma | 19.89B |
| China Merchants Property Operation & Service | 19.58B |
| Sunvim Group Co.,Ltd | 5.26B |
| Better Life Commercial Chain Share Co.,Ltd | 4.37B |
| CITIC Guoan Information Industry | 3.35B |
| Shenzhen SOFARSOLAR | 2.58B |
| SanFeng Intelligent Equipment Group | 1.70B |
| Capitalonline Data Service | 1.28B |